Hiroshi Ogawara

7.3k citations
123 papers · 6.3k indexed · 2 hit papers · h-index 24
Topics
Microbial Natural Products and Biosynthesis (43 papers)Antibiotic Resistance in Bacteria (19 papers)Carbohydrate Chemistry and Synthesis (16 papers)
Partner nations
JapanUnited StatesIndia

In The Last Decade

Hiroshi Ogawara

119 papers receiving 6.0k citations

Hit Papers

Genistein, a specific inhibitor of tyrosine-specific prot...19862026199920121987198610002.0k3.0k

Peers

Hiroshi Ogawara
Comparison fields: 5 of 137
  • Molecular Biology 3.1k
  • Pathology and Forensic Medicine 1.4k
  • Oncology 1.3k
  • Genetics 982
  • Pharmacology 609
Replace Tse‐Hua Tan with:
Tse‐Hua Tan United States
Richard A. Franklin United States
Ralf Schreck Germany
Gail E. Sonenshein United States
Marty W. Mayo United States
Melchiorre Cervello Italy
Airo Tsubura Japan
Shile Huang United States
George P. Studzinski United States
Anning Lin United States
Hiroshi Ogawara relative to Tse‐Hua Tan United States Tse‐Hua Tan's profile →
Citations per field
00.5×1.5×2.0×
Tse‐Hua Tan · 1×
Citations per year

Countries citing papers authored by Hiroshi Ogawara

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ogawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ogawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ogawara more than expected).

Fields of papers citing papers by Hiroshi Ogawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ogawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ogawara. The network helps show where Hiroshi Ogawara may publish in the future.

Co-authorship network of co-authors of Hiroshi Ogawara

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ogawara. A scholar is included among the top collaborators of Hiroshi Ogawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ogawara. Hiroshi Ogawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 44
2 9
3 8
4 18
5 4
6 9
7 2
8 17
9 1
10 22
11 375
12
INHIBITION OF INOSITOL PHOSPHOLIPID SIGNALING BY ISOFLAVONE COMPOUNDS
2
13 102
14 7
15 68
16
A SPECIFIC INHIBITOR FOR TYROSINE PROTEIN KINASE
1
17 16
18 14
19 16
20 5

About Hiroshi Ogawara

Hiroshi Ogawara is a scholar working on Molecular Medicine, Pharmacology and Microbiology, having authored 123 papers that have together received 6.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (43 papers), Antibiotic Resistance in Bacteria (19 papers) and Carbohydrate Chemistry and Synthesis (16 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Molecular Medicine (301 citations) and Oncology (1.3k citations). Hiroshi Ogawara has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Tetsu Akiyama, Shun‐ichi Watanabe, Yuko Fukami, Shizue Nakagawa, Masabumi Shibuya, Junko Ishida, Kumao Toyoshima, Tadashi Yamamoto, Michiko Nakano and Eisuke Nishida. Their work appears in journals such as Science, Journal of Biological Chemistry and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026